Literature DB >> 17453305

Relative effects of barrier precautions and topical antibiotics on nosocomial bacterial transmission: results of multi-compartment models.

B Boldin1, M J M Bonten, O Diekmann.   

Abstract

Nosocomial bacterial infections in critically ill patients are generally preceded by asymptomatic carriage (i.e. colonization) at one, or even several, body sites such as the skin, the gastro-intestinal and the respiratory tract. Different routes of transmission between the colonized sites create a complex epidemiology, which is additionally complicated by the smallness of the patient population size and the rapid patient turnover, characteristic for intensive care units (ICUs). Naturally occurring large fluctuations in the prevalence of colonization make it very difficult to determine the efficacy of control measures that aim to reduce the prevalence of antibiotic-resistant bacteria in ICUs. Theoretical models can sharpen our intuition through carefully designed thought experiments. In this spirit, we introduce and investigate two models that incorporate the fact that patients may be colonized at multiple body sites. Our study can be applied to several pathogens commonly found in ICUs, such Pseudomonas Aeruginosa, enteric Gram-negative bacteria, MRSA and enterococci. We evaluate the effects of barrier precautions (improved hygiene, use of gloves and gowns, etc.) and of administration of nonabsorbable antibiotics on the prevalence of colonization in ICUs and find that the effect of the controversial, though widely used, antibiotic prophylaxis can only be substantial if the patient-to-patient transmission has already been reduced to a subcritical level by barrier precautions. Taking into account that the very use of antibiotics may increase the selection for resistant strains and may thereby only add to the ever increasing problem of antibiotic resistance, our findings hence represent a firm theoretical argument against the routine use of topical antimicrobial prophylaxis for infection control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17453305      PMCID: PMC2799002          DOI: 10.1007/s11538-007-9205-1

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   1.758


  13 in total

1.  Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  D C Bergmans; M J Bonten; C A Gaillard; J C Paling; S van der Geest; F H van Tiel; A J Beysens; P W de Leeuw; E E Stobberingh
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

Review 2.  Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control.

Authors:  M J Bonten; D J Austin; M Lipsitch
Journal:  Clin Infect Dis       Date:  2001-10-10       Impact factor: 9.079

Review 3.  All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth.

Authors:  Hendrick K F van Saene; Andy J Petros; Graham Ramsay; Derrick Baxby
Journal:  Intensive Care Med       Date:  2003-04-10       Impact factor: 17.440

4.  Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial.

Authors:  Wolfgang A Krueger; Franz-Peter Lenhart; Gertraud Neeser; Gotthart Ruckdeschel; Heidi Schreckhase; Hans-Joachim Eissner; Helmuth Forst; Joachim Eckart; Klaus Peter; Klaus E Unertl
Journal:  Am J Respir Crit Care Med       Date:  2002-10-15       Impact factor: 21.405

5.  Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients.

Authors:  M J Bonten; D C Bergmans; A W Ambergen; P W de Leeuw; S van der Geest; E E Stobberingh; C A Gaillard
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

6.  Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial.

Authors:  Miguel A de La Cal; Enrique Cerdá; Paloma García-Hierro; Hendrick K F van Saene; Dulce Gómez-Santos; Eva Negro; José Angel Lorente
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

7.  The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable.

Authors:  M J Bonten; S Slaughter; A W Ambergen; M K Hayden; J van Voorhis; C Nathan; R A Weinstein
Journal:  Arch Intern Med       Date:  1998-05-25

8.  Changing bacterial ecology during a five-year period of selective intestinal decontamination.

Authors:  W Lingnau; J Berger; F Javorsky; M Fille; F Allerberger; H Benzer
Journal:  J Hosp Infect       Date:  1998-07       Impact factor: 3.926

Review 9.  Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization.

Authors:  Mark B Loeb; Cheryl Main; Angela Eady; Cindy Walker-Dilks
Journal:  Cochrane Database Syst Rev       Date:  2003

10.  Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit.

Authors:  C Brun-Buisson; P Legrand; A Rauss; C Richard; F Montravers; M Besbes; J L Meakins; C J Soussy; F Lemaire
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

View more
  9 in total

1.  Bifurcation analysis and global dynamics of a mathematical model of antibiotic resistance in hospitals.

Authors:  Xiuli Cen; Zhilan Feng; Yiqiang Zheng; Yulin Zhao
Journal:  J Math Biol       Date:  2017-04-10       Impact factor: 2.259

2.  Qualitative analysis of models with different treatment protocols to prevent antibiotic resistance.

Authors:  Hong-Rui Sun; Xinxin Lu; Shigui Ruan
Journal:  Math Biosci       Date:  2010-06-25       Impact factor: 2.144

Review 3.  Modelling the transmission of healthcare associated infections: a systematic review.

Authors:  Esther van Kleef; Julie V Robotham; Mark Jit; Sarah R Deeny; William J Edmunds
Journal:  BMC Infect Dis       Date:  2013-06-28       Impact factor: 3.090

4.  The impact of different antibiotic regimens on the emergence of antimicrobial-resistant bacteria.

Authors:  Erika M C D'Agata; Myrielle Dupont-Rouzeyrol; Pierre Magal; Damien Olivier; Shigui Ruan
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

Review 5.  Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens?

Authors:  Caroline Landelle; Leonardo Pagani; Stephan Harbarth
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

6.  Structure-function aspects of PstS in multi-drug-resistant Pseudomonas aeruginosa.

Authors:  Olga Zaborina; Christopher Holbrook; Yimei Chen; Jason Long; Alexander Zaborin; Irina Morozova; Hoylan Fernandez; Yingmin Wang; Jerrold R Turner; John C Alverdy
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

Review 7.  Simulation models for transmission of health care-associated infection: A systematic review.

Authors:  Le Khanh Ngan Nguyen; Itamar Megiddo; Susan Howick
Journal:  Am J Infect Control       Date:  2019-12-18       Impact factor: 2.918

8.  Controlling nosocomial infection based on structure of hospital social networks.

Authors:  Taro Ueno; Naoki Masuda
Journal:  J Theor Biol       Date:  2008-07-04       Impact factor: 2.691

9.  Evaluation of GeneXpert PA assay compared to genomic and (semi-)quantitative culture methods for direct detection of Pseudomonas aeruginosa in endotracheal aspirates.

Authors:  Thomas Ewout van der Schalk; Jasmine Coppens; Leen Timbermont; Agata Turlej-Rogacka; Liesbet Van Heirstraeten; Matilda Berkell; Li Yu; Christine Lammens; Basil Britto Xavier; Veerle Matheeussen; Margareta Ieven; Michael McCarthy; Philippe G Jorens; Alexey Ruzin; Mark T Esser; Samir Kumar-Singh; Herman Goossens; Surbhi Malhotra-Kumar
Journal:  Antimicrob Resist Infect Control       Date:  2021-07-23       Impact factor: 4.887

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.